
Retatrutide
Retatrutide is a clinical-stage triple agonist of the GIP, GLP-1 and glucagon receptors.

EU Warehouse
Tesamorelin is a stabilized growth hormone-releasing hormone analogue.
ELVORA RESEARCH
Randomized clinical trials and FDA labeling support an approved medicine for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. It is not indicated for general weight management, and long-term cardiovascular safety has not been established.
External primary and regulatory sources for factual context. Not guidance on use.
Batch documents
Verified batch-specific laboratory reports are linked here without alteration.
View all certificatesNo verified COA is currently available for this product.
Continue through the catalogue

Retatrutide is a clinical-stage triple agonist of the GIP, GLP-1 and glucagon receptors.

Tirzepatide is a dual GIP and GLP-1 receptor agonist.

BPC-157 is a synthetic pentadecapeptide studied in preclinical tissue and repair research.